迈威生物(688062)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688062 迈威生物

已收盘 07-22 15:00:00

{"stockData":{"symbol":"688062","market":"SH","secType":"STK","nameCN":"迈威生物","latestPrice":27.58,"timestamp":1721631600000,"preClose":26.8,"halted":0,"volume":5025442,"delay":0,"floatShares":204000000,"shares":400000000,"eps":-2.5476,"marketStatus":"已收盘","marketStatusCode":5,"change":0.78,"latestTime":"07-22 15:00:00","open":25.98,"high":27.94,"low":25.98,"amount":138000000,"amplitude":0.0731,"askPrice":27.58,"askSize":145,"bidPrice":27.56,"bidSize":64,"shortable":0,"etf":0,"ttmEps":-2.5476,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721698200000},"adr":0,"adjPreClose":26.8,"symbolType":"stock_kcb","openAndCloseTimeList":[[1721611800000,1721619000000],[1721624400000,1721631600000]],"highLimit":29.48,"lowLimit":24.12,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":399600000,"pbRate":4.58,"roa":"--","roe":"--","epsLYR":-2.64,"committee":-0.206349,"marketValue":11021000000,"floatMarketCap":5631000000,"peRate":-10.825875,"changeRate":0.0291,"turnoverRate":0.0246,"status":0,"afterMarket":{"amount":0,"volume":0,"close":27.58,"buyVolume":0,"sellVolume":0,"time":1721633637153,"indexStatus":"已收盘 07-22 15:30:00","preClose":26.8}},"requestUrl":"/m/hq/s/688062","defaultTab":"news","newsList":[{"id":"2453783306","title":"单抗概念盘中拉升，迈威生物-U涨2.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453783306","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453783306?lang=zh_cn&edition=full","pubTime":"2024-07-22 09:50","pubTimestamp":1721613008,"startTime":"0","endTime":"0","summary":"07月22日，单抗概念盘中拉升，截至09点50分，单抗概念整体指数上涨0.56%，报1681.720点。从个股上来看，该概念的成分股中，迈威生物-U涨2.61%，丽珠集团、天士力、三生国健涨幅居前。从资金上来看，截止发稿，单抗概念概念主力净流入为-7074.78万，其中天士力受到资金热捧，主力净流入983.99万；拉长时间线来看，该板块近20日主力资金净流入-11.91亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407220950089681eb5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407220950089681eb5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600535","BK0239","688062"],"gpt_icon":0},{"id":"2452493346","title":"迈威生物-U大跌5.16% 北向资金连续2日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2452493346","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452493346?lang=zh_cn&edition=full","pubTime":"2024-07-19 09:30","pubTimestamp":1721352615,"startTime":"0","endTime":"0","summary":"07月19日，迈威生物-U股价大幅下跌，截至09点30分，迈威生物-U下跌5.16%，报28.50元/股，失守30元整数关口，成交680万元，换手率0.11%，振幅4.06%。资金动向截止发稿，迈威生物-U获得主力净流出194万元，其中超大单流出247万元，大单流入54万元。北向资金方面，迈威生物-U07月18日获得北向资金减持84.99万股，截至07月18日，北向资金当前共持有迈威生物-U644.15万股，市值1.84亿元，持股占流通股比为3.15%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719093041af930e56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719093041af930e56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688062"],"gpt_icon":0},{"id":"2452112558","title":"迈威生物（688062）7月17日主力资金净买入338.17万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452112558","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452112558?lang=zh_cn&edition=full","pubTime":"2024-07-18 08:14","pubTimestamp":1721261642,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月17日收盘，迈威生物报收于28.98元，上涨2.8%，换手率1.19%，成交量2.43万手，成交额6976.11万元。近5日资金流向一览见下表：迈威生物融资融券信息显示，融资方面，当日融资买入263.34万元，融资偿还137.54万元，融资净买入125.81万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071800012966.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688062"],"gpt_icon":0},{"id":"2452135082","title":"迈威生物一款小细胞肺癌创新药在美国获孤儿药资格认定","url":"https://stock-news.laohu8.com/highlight/detail?id=2452135082","media":"新京报","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452135082?lang=zh_cn&edition=full","pubTime":"2024-07-17 17:28","pubTimestamp":1721208480,"startTime":"0","endTime":"0","summary":"7月16日，迈威生物宣布，其自主研发的靶向B7-H3ADC创新药获美国食品药品监督管理局授予孤儿药资格认定，用于治疗小细胞肺癌。7MW3711基于迈威生物新一代ADC定点偶联技术平台IDDC开发，由创新抗体分子、新型连接子以及新型载荷Mtoxin构成，具有完全知识产权。在食蟹猴等动物安全性评价模型中，7MW3711显示具良有好的药物安全性及药代特性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407171730419f5c66fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407171730419f5c66fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","159992","688062"],"gpt_icon":0},{"id":"2451615939","title":"迈威生物靶向 B7-H3 ADC 创新药 7MW3711 获 FDA 孤儿药资格认定","url":"https://stock-news.laohu8.com/highlight/detail?id=2451615939","media":"迈威生物","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451615939?lang=zh_cn&edition=full","pubTime":"2024-07-16 11:30","pubTimestamp":1721100638,"startTime":"0","endTime":"0","summary":"重要新闻迈威生物 ，一家全产业链布局的创新型生物制药公司，宣布其自主研发的靶向 B7-H3 ADC 创新药获美国食品药品监督管理局授予孤儿药资格认定 ，用于治疗小细胞肺癌。FDA 授予的孤儿药资格认定适用于在美国地区少于 20 万患者的罕见病的药物。其中靶向 Nectin-4 ADC 创新药 9MW2821 在尿路上皮癌适应症已处于 III 期临床研究阶段。靶向 B7-H3 ADC 创新药 7MW3711 和靶向 Trop-2 ADC  创新药 9MW2921 均已处于临床试验阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407161210199f537452&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407161210199f537452&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159992","BK0239","688062"],"gpt_icon":0},{"id":"2451598177","title":"迈威生物（688062）7月12日主力资金净卖出236.68万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451598177","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451598177?lang=zh_cn&edition=full","pubTime":"2024-07-13 08:12","pubTimestamp":1720829557,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月12日收盘，迈威生物报收于29.15元，上涨4.07%，换手率1.47%，成交量3.01万手，成交额8810.97万元。近5日资金流向一览见下表：迈威生物融资融券信息显示，融资方面，当日融资买入277.42万元，融资偿还265.62万元，融资净买入11.8万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071300012304.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688062"],"gpt_icon":0},{"id":"2450588638","title":"迈威生物(688062)：全链条渐进式创新 即将收获差异化成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2450588638","media":"东方证券","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450588638?lang=zh_cn&edition=full","pubTime":"2024-07-12 18:34","pubTimestamp":1720780470,"startTime":"0","endTime":"0","summary":"公司目前已有3 款生物类似药获批上市，潜在同类最佳创新产品Nectin-4 ADC 处于关键临床III 期试验。公司凭借全链条及前瞻性布局，早期以生物类似药开发为先导，目前已有3 款生物类似药产品成功商业化。其中，阿达木单抗于2022 年获批， 2023 年完成发货 16.7 万支。地舒单抗于2024 年3 月29 日获批成为国内安加维首款生物类似药。风险提示创新药研发进度不及预期、生物类似药品种进入集采、产品竞争加剧或者销售不及预期、公司中长期盈利能力下降的风险等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407121834339f3b2e9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407121834339f3b2e9b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688062"],"gpt_icon":0},{"id":"2450327422","title":"迈威生物新提交1件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2450327422","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450327422?lang=zh_cn&edition=full","pubTime":"2024-07-12 13:05","pubTimestamp":1720760735,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示，近日迈威（上海）生物科技股份有限公司新提交1件商标注册申请。商标申请详情如下：今年以来迈威（上海）生物科技股份有限公司新申请注册商标2件，截止目前公司共持有注册商标630件，另有98件商标尚在注册申请中。数据来源：企查查以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071200023281.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688062","BK0239"],"gpt_icon":0},{"id":"2450834030","title":"新冠药物概念盘中拉升，迈威生物-U涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450834030","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450834030?lang=zh_cn&edition=full","pubTime":"2024-07-12 09:53","pubTimestamp":1720749187,"startTime":"0","endTime":"0","summary":"07月12日，新冠药物概念盘中拉升，截至09点53分，新冠药物概念整体指数上涨1.16%，报455.000点。从个股上来看，该概念的成分股中，迈威生物-U涨5.00%，河化股份、泓博医药、海创药业-U涨幅居前。从资金上来看，截止发稿，新冠药物概念主力净流入为-991.19万，其中诺泰生物受到资金热捧，主力净流入2183.61万；拉长时间线来看，该板块近20日主力资金净流入-27.52亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712095307af91f60e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712095307af91f60e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688062"],"gpt_icon":0},{"id":"2450871197","title":"北向资金7月10日净买入迈威生物-U52.40万股 连续5日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2450871197","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450871197?lang=zh_cn&edition=full","pubTime":"2024-07-11 09:30","pubTimestamp":1720661439,"startTime":"0","endTime":"0","summary":"7月10日, 北向资金增持迈威生物-U52.40万股，连续5日增持。截止当日收盘，沪股通共持有迈威生物-U697.28万股，占流通股3.41%。沪股通增持金额前五个股分别为长江电力、隆基绿能、海尔智家、贵州茅台、中国平安。迈威生物-U近5个交易日下跌1.06%，沪股通累计增持197.92万股；近20个交易日下跌17.16%，沪股通累计减持104.57万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407110935239f310a08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407110935239f310a08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688062"],"gpt_icon":0},{"id":"2450609894","title":"迈威生物-U大跌5.05% 北向资金连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2450609894","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450609894?lang=zh_cn&edition=full","pubTime":"2024-07-09 14:49","pubTimestamp":1720507744,"startTime":"0","endTime":"0","summary":"07月09日，迈威生物-U股价大幅下跌，截至14点49分，迈威生物-U下跌5.05%，报26.69元/股，创近4月新低，成交1.34亿元，换手率2.43%。资金动向截止发稿，迈威生物-U获得主力净流出1217万元，其中超大单流出1734万元，大单流入518万元。北向资金方面，迈威生物-U07月08日获得北向资金增持4.26万股，连续3日增持，截至07月08日，北向资金当前共持有迈威生物-U566.47万股，市值1.51亿元，持股占流通股比为2.77%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709144927aef89f83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709144927aef89f83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688062","BK0239"],"gpt_icon":0},{"id":"2450055610","title":"北向资金7月8日净买入迈威生物-U4.26万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2450055610","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450055610?lang=zh_cn&edition=full","pubTime":"2024-07-09 09:30","pubTimestamp":1720488636,"startTime":"0","endTime":"0","summary":"7月8日, 北向资金增持迈威生物-U4.26万股，连续3日增持。截止当日收盘，沪股通共持有迈威生物-U566.47万股，占流通股2.77%。沪股通增持金额前五个股分别为长江电力、澜起科技、中国平安、中国核电、农业银行。迈威生物-U近5个交易日上涨1.04%，沪股通累计增持127.70万股；近20个交易日下跌11.16%，沪股通累计减持244.22万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407090935099593df78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407090935099593df78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688062"],"gpt_icon":0},{"id":"2449232217","title":"7月8日迈威生物-U跌5.00%，汇添富达欣混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2449232217","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449232217?lang=zh_cn&edition=full","pubTime":"2024-07-08 16:11","pubTimestamp":1720426299,"startTime":"0","endTime":"0","summary":"证券之星消息，7月8日迈威生物-U跌5.00%，收盘报28.11元，换手率1.94%，成交量3.96万手，成交额1.14亿元。重仓迈威生物-U的前十大公募基金请见下表：该股最近90天内共有8家机构给出评级，买入评级7家，增持评级1家；过去90天内机构目标均价为44.6。根据2024基金Q1季报公募基金重仓股数据，重仓该股的公募基金共78家，其中持有数量最多的公募基金为汇添富达欣混合A。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070800020146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688062"],"gpt_icon":0},{"id":"2449746745","title":"迈威生物-U大跌5.37% 北向资金增持24.34万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2449746745","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449746745?lang=zh_cn&edition=full","pubTime":"2024-07-08 13:56","pubTimestamp":1720418179,"startTime":"0","endTime":"0","summary":"07月08日，迈威生物-U股价大幅下跌，截至13点56分，迈威生物-U下跌5.37%，报28.00元/股，成交8368万元，换手率1.41%。资金动向截止发稿，迈威生物-U获得主力净流入203万元，其中超大单流入242万元，大单流出38万元。北向资金方面，迈威生物-U07月05日获得北向资金增持24.34万股，截至07月05日，北向资金当前共持有迈威生物-U562.21万股，市值1.57亿元，持股占流通股比为2.75%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708135651af90fb6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708135651af90fb6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688062","BK0239"],"gpt_icon":0},{"id":"2449258347","title":"广东探索药采新政，创新药ETF(159992)实时净申购超4000万份，迪哲医药-U、迈威生物-U、美迪西领涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2449258347","media":"和讯网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449258347?lang=zh_cn&edition=full","pubTime":"2024-07-05 14:26","pubTimestamp":1720160777,"startTime":"0","endTime":"0","summary":"2024年7月5日，创新药板块大幅修复。盘面上，迪哲医药-U领涨，迈威生物-U、美迪西跟涨，创新药ETF市场热度较高，过去5个交易日日均成交额达1.54亿元。此举标志着广东省在深化医疗保障制度改革、优化药品供应保障体系方面迈出了新的一步此措施有助于进一步规范药品市场，保障公众用药需求，提高药品可及性、促进创新药行业健康发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705160533957b0dc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705160533957b0dc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688062","515120","BK0216","159992","688202","688192","BK0239"],"gpt_icon":0},{"id":"2448952115","title":"迈威生物获北向资金买入1775.93万元，累计持股502.71万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2448952115","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448952115?lang=zh_cn&edition=full","pubTime":"2024-07-03 07:27","pubTimestamp":1719962824,"startTime":"0","endTime":"0","summary":"7月3日，巨灵财经数据显示，北向资金2日增持迈威生物预估1775.93万元，累计持股502.71万股，总计持有市值1.39亿元，占流通股比例2.46%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407030732269569cc3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407030732269569cc3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688062"],"gpt_icon":0},{"id":"2448242184","title":"迈威生物连跌4天，汇添富基金旗下2只基金位列前十大股东","url":"https://stock-news.laohu8.com/highlight/detail?id=2448242184","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448242184?lang=zh_cn&edition=full","pubTime":"2024-07-02 16:09","pubTimestamp":1719907788,"startTime":"0","endTime":"0","summary":"7月2日，迈威生物连续4个交易日下跌，区间累计跌幅-9.94%。财报显示，汇添富基金旗下2只基金进入迈威生物前十大股东，且为今年一季度新进。2023年11月23日任汇添富全球医疗保健混合型证券投资基金基金经理。资料显示，汇添富基金管理股份有限公司成立于2005年2月，董事长为李文，总经理为张晖。目前，汇添富基金共有3名股东，东方证券股份有限公司持股47%、上海上报资产管理有限公司持股26.50%、东航金控有限责任公司持股26.50%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070216135095652086&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070216135095652086&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688062"],"gpt_icon":0},{"id":"2448927278","title":"迈威生物（688062）7月1日主力资金净买入63.70万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448927278","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448927278?lang=zh_cn&edition=full","pubTime":"2024-07-02 08:21","pubTimestamp":1719879677,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月1日收盘，迈威生物报收于27.82元，下跌3.87%，换手率2.64%，成交量5.39万手，成交额1.49亿元。近5日资金流向一览见下表：迈威生物融资融券信息显示，融资方面，当日融资买入444.37万元，融资偿还368.08万元，融资净买入76.3万元，连续3日净买入累计166.19万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070200004468.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688062"],"gpt_icon":0},{"id":"2448229349","title":"【机构调研记录】鹏华基金调研湖南裕能、迈威生物等8只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2448229349","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448229349?lang=zh_cn&edition=full","pubTime":"2024-07-02 08:02","pubTimestamp":1719878551,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及7月1日披露的机构调研信息，鹏华基金近期对8家上市公司进行了调研，相关名单如下：1）湖南裕能 个股亮点：公司主营为锂离子电池正极材料，已供货给比亚迪等新能源汽车客户；公司在国内正极材料领域市场占有率达到25%,磷酸铁锂出货量排名第一；公司设立湖南裕能循环开展锂电池回收业务2）迈威生物 个股亮点：公司9MW2821是公司研发的一款靶向Nectin-4的ADC型创新药。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407020804099ef04f91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407020804099ef04f91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["301358","BK0239","688062","BK0214"],"gpt_icon":0},{"id":"2448116922","title":"【机构调研记录】东吴证券调研一汽解放、迈威生物等5只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2448116922","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448116922?lang=zh_cn&edition=full","pubTime":"2024-07-02 08:02","pubTimestamp":1719878550,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及7月1日披露的机构调研信息，东吴证券近期对5家上市公司进行了调研。2）迈威生物 个股亮点：公司9MW2821是公司研发的一款靶向Nectin-4的ADC型创新药。5）通威股份 个股亮点：公司在硅料和电池片两个环节的产能及生产成本均处于行业领先地位，并且正处于激进的扩产进程中。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070200004191.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601555","BK0239","BK0006","688062","BK0264","BK0010","BK0012","BK0188","BK0009","BK0276","BK0028","BK0183","BK0057","000800"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2022-01-18","address":"上海市浦东新区中国(上海)自由贸易试验区蔡伦路230号2幢105室","stockEarnings":[{"period":"1week","weight":-0.0806},{"period":"1month","weight":-0.1769},{"period":"3month","weight":-0.1265},{"period":"6month","weight":-0.0596},{"period":"1year","weight":0.2829},{"period":"ytd","weight":-0.1802}],"companyName":"迈威(上海)生物科技股份有限公司","boardCode":"AI0027","perCapita":"13667股","boardName":"医药制造业","registeredCapital":"39960万元","compareEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":-0.0118},{"period":"3month","weight":-0.0271},{"period":"6month","weight":0.053},{"period":"1year","weight":-0.0591},{"period":"ytd","weight":0.0025}],"survey":"　　迈威(上海)生物科技股份有限公司是一家创新型生物制药企业，主营业务为治疗用生物制品的研发、生产与销售，主要产品为抗体药物。截至本招股说明书签署日，新增授权专利4项，新增专利申请48项，独立承担1项国家“重大新药创制”重大科技专项，独立承担2项国家重点研发计划。","serverTime":1721642434227,"listedPrice":34.8,"stockholders":"14938人(较上一季度减少16.14%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"迈威生物(688062)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供迈威生物(688062)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"迈威生物,688062,迈威生物股票,迈威生物股票老虎,迈威生物股票老虎国际,迈威生物行情,迈威生物股票行情,迈威生物股价,迈威生物股市,迈威生物股票价格,迈威生物股票交易,迈威生物股票购买,迈威生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"迈威生物(688062)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供迈威生物(688062)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}